Aspirin Resistance
9
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery
Aspirin Resistance Reversibility in Diabetic Patients
Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients
The Effect of Serum LDL Lowering on Aspirin Resistance
Platelet Reactivity and MES During CEA
Mechanism Based Resistance to Aspirin